Patient Rating:

4.9 out of 5

84 Patient Ratings
101 Patient Comments

John W. Rose, M.D.

Chief, Division of Neuroimmunology

Patient Rating:

4.9 out of 5

84 Patient Ratings
101 Patient Comments



  • English

Clinical Details

Phone Number Clinical Office Address
(801) 585-7575 Imaging and Neurosciences Center
729 Arapeen Way
Salt Lake City, UT 84108



John Rose, MD is Professor of Neurology at the University of Utah and is Chief of Neurology at the Salt Lake City Veterans Administration Hospital. Dr. Rose and his colleagues investigate diverse aspects of multiple sclerosis (MS), including the immunopathology of MS and related models, the development of new treatments for MS, early disease detection with advanced magnetic resonance imaging, and the detection of susceptibility genes for MS.

Board Certification and Academic Information

Academic Departments Neurology - Professor
Academic Divisions Neuroimmunology
Board Certification American Board of Psychiatry & Neurology (Neurology)
National Board of Medical Examiners

Patient Ratings

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Likelihood of recommending care provider
My confidence in care provider
Time care provider spent with me
Care provider spoke using clear language
Care provider's effort to include me in decisions
Care provider's concern for questions & worries
Care provider's explanation of condition/problem
Wait time at clinic
Care provider's friendliness and courtesy

Patient Comments

Patient comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

July 26, 2015

I have always felt very comfortable and happy with the care and concern I have received over the years from dr. Rose.

July 12, 2015

Dr Rose is a wonderful caring doctor

June 22, 2015

Dr. Rose makes sure that I understand the test results medical treatments and success rate compared to other patients. He evaluates the effectiveness of the medication in my particular case. He is mindful of any of my "complications" (symptoms) and makes suggestions to handle them.

June 10, 2015

Dr. Rose is an excellent neurologist, but he has a tendency to spend so much time with patients that the wait time is horrendous.

April 12, 2015

Dr. Rose is kind, considerate and very aware of my concerns. He takes the time to listen and to make sure I understand my options. He is easy to talk to and has a wonderful sense of humor -- at least he appreciates my humor!!

April 03, 2015

Dr. has treated me since 1985. I have always been very happy with him.

April 01, 2015

Excellent on all accounts.

March 20, 2015

Dr. Rose is the best, that's why so busy, busy.

March 08, 2015


February 22, 2015

very good!

February 22, 2015

Dr. Rose is a gentleman.

February 11, 2015

Dr Rose always is kind and keeps me informed of my progress and explains everything so that I can understand.

February 03, 2015


January 28, 2015

My questions were answered as well as related, helpful information provided. I appreciate the efficient, yet unhurried climate of the visit. I appreciate the opportunity to map out come of the objectives for the next visit, in six months. This pro-active approach is a long-term management strategy of the disease that I really appreciate.

January 13, 2015

I feel that Dr. Rose is one of the top multiple sclerosis physicians anywhere and I am lucky to have him as my doctor.

January 12, 2015


December 18, 2014

Dr. Rose is great. He always takes the time to explain everything and answer questions.

December 06, 2014

Dr. Rose has always gone the extra mile in my treatment of MS. has a unique ability to make me feel comfortable through the process.

October 30, 2014

Dr. Rose is one of the very best and I couldn't be luckier to be seeing him!

October 11, 2014

Dr. Rose is so compassionate and his questions are so good -- he really listens to what I say and comments or ask questions about what I bring up. He spends as much time with me as I need, I never feel rushed. He keeps up on the latest information and shares it with me when I ask about things I've heard or learned.

September 20, 2014

Dr. Rose - one of the best Doctors.

September 06, 2014

Very understandable if any questions asked.

August 07, 2014

Dr.Rose is wonderful. He spends a lot of time with me during my appointment so I plan on waiting when I get to my appointment because I know he's spending the extra time with his other patients as well.

August 07, 2014

I'm very fortunate to have Dr. Rose as my doctor.

August 05, 2014


July 27, 2014

I felt like I had no choice in my treatment this time. I had no return call last appt for pharmacist question nor for blood work to continue techfidera. long term disability was skirted over as cognitive would need to be tested and 6 months out with cost concerns. Not happy after this visit with Dr. Rose!!!

June 24, 2014

I have recommended Dr. Rose to family and friends with MS. He is the very best.

June 16, 2014

I have always had a good experience.

May 10, 2014

The best!

May 08, 2014

very good

April 25, 2014

Dr. Rose is absolutely excellent

April 24, 2014

I have recommended Dr Rose to a lot of people, I have gone to him for years I like going to the U and I will continue to stay with Dr Rose even after I move back to Las Vegas.

April 22, 2014

John Rose is an amazing provider. His care and expertise are incredible!

April 18, 2014

Dr.Rose is awesome. I am very lucky to have him for my doctor.

April 11, 2014

Dr is extremely knowledgable about my condition and has always treated me in a kind way.

March 17, 2014

Dr. Rose is the best! I don't know what I would do without him.

March 13, 2014

Dr. Rose and his staff have always been great!

March 06, 2014

Dr. Rose is a great doctor

March 04, 2014

I feel extremely fortunate to now be under the care of Dr. Rose.

March 02, 2014

I was very impressed with the compassion and time everyone allowed me in order to understand my health history, future and other concerns.

February 09, 2014

Very grateful to have Dr Rose.

February 03, 2014

I feel very lucky to have Dr. Rose treating me!

February 02, 2014

I quite like Dr. Rose. I feel comfortable with him

January 08, 2014

Dr. Rose is always helpful and does not rush through my appointment. Because of this, I was ok with him not being "on time". I knew he was helping the other patients.

November 18, 2013

he is the BEST!

November 18, 2013

He seemed a little less engaged than in previous visits. It appeared to ruffle his feathers just a bit when I questioned the cost and effectiveness of the DMDs proffered by big pharma. I think I touched a nerve there. I am close to having no medical coverage and do not relish the thought of paying exhorbitant retail prices in the US.

November 11, 2013

The reason I gave such a low rating on question #8 is he spent 10 minutes interacting with me personally.

November 04, 2013

Dr. Rose listens and provides research and information to help answer my questions and to include me in decisions about treatment. He is thoughtful and patient in taking the time to give me all the information I need to feel comfortable with my treatment decision.

October 28, 2013

Dr. Rose is the best and I am blessed to have him as my Neurologist

October 26, 2013

He is always very efficient.

October 24, 2013

Dr.Rose takes time with me every time I see him (every 6 months) to thoroughly test my reflexes, balance,eyes, etc.

October 17, 2013

always very kind and caring

October 03, 2013

Dr. Rose was very friendly and provided excellent care. He was attentive to my needs and concerns. He was teaching a third year medical student. Both he and the medcial student were excellent.

August 21, 2013

I'm sticking with Dr Rose until he retires :)

August 05, 2013

I have already recommended Dr. Rose to others

July 28, 2013

Dr. Rose and his 2 students were friendly and helpful.The only thing I felt that did not get addressed was my concern that my legs feel like they are getting weaker. I had hoped to discuss possible physical therapy but forgot to bring it up.

July 22, 2013

Dr. Rose listens to my concerns and that is very important to me. He always includes me in decisions about my treatment and I have complete confidence in the care he provides me.

July 08, 2013

I have already recommended Dr. Rose to several people, and hold him in high regards. He always goes the extra mile, even when you can tell he's having a not so great day.

June 25, 2013

Everything seems to flow well with the group, even though at times they have their hands full with lots of patients, the nurses remain friendly and spend the time needed for each patient. I feel they put people at ease, as much as possible.

June 20, 2013

Dr. Rose is amazing!! I am so thankful to have someone treating my MS like him. He stays on top of all of the new meds and knows his patients well enough to know if they are a good fit for a treatment. He has a wealth of knowledge about MS!! I can't say enough good things about him.

May 07, 2013

I feel I'm receiving the highest possiible standard of care and appreciate the doctors consideration of my concerns.

May 05, 2013

Dr. Rose was very caring, thorough, and thoughtful during my visit. He took the time to explain things and answer any questions I had. He did not seem at all to be rushing me through. I am very pleased that Dr. Rose made this such a comfortable and positive visit.

April 30, 2013

Dr.Rose is great and I feel very confident in him.

April 16, 2013

My experience was very good, as usual.

April 12, 2013

The only comment I have about Dr. Rose is that knowing that MS is extremely individual as to the degree of the worsening. I feel it is worsening at a faster rate than I think it should. I would just like some feedback as to the worsening of the physical disability. A doctor's perspective can illuminate just how quickly my MS is progressing

April 02, 2013

Liked the way Dr. Rose replied "that would be unusual" or "that's unlikely" when asked about whether a particular symptom is associated with MS, instead of saying "no, that's not because of MS". This disease and the info on it is constantly changing.

April 01, 2013

Dr. Rose is the very best and I would fly anywhere to see him.

March 18, 2013

Dr. Rose is very caring toward me.

February 25, 2013

Dr Rose is Awesome!

February 25, 2013

Very good

February 18, 2013

I love Dr. Rose. He never lets you walk away wondering about anything. He also never talks down to me, he treats me as though I am actually an intelligent person.

February 11, 2013

Dr. Rose is always patient and thoughtful in his responses.

January 03, 2013

Doctor John Rose...He accepted me as a new patient when he wasn't openly even accepting more patients in the beginning of my trying to figure out what was wrong with me. He's been open, easily accessible, kind, and down to earth since the very first appointment. Having to go through mind and life changing health problems, I'm just glad I have him to be my guide along the way.

December 20, 2012

There was a mistake in my MRI report that I noticed only afterwards! It is uncomfortable that this didn't come up during the appointment.

December 07, 2012

My previous care was at USC medical center an amazing clinic! I was with them many years. It felt wonderful to feel as though I would get the same wonderful and thorough care here.

December 03, 2012

Dr. Rose is the best in his treatment of me as a patient.

November 16, 2012

The Saturday experience was very different from the Thursday and Friday experience at the same infusion lab, I would recommend not going on a Saturday for infusion, horrible experience. I still have the bruises from the failed injections, 3 weeks later.

November 01, 2012

Dr. Rose has been so wonderful, he is truly concerned about my illness and I know that I am receiving the best treatment possible! He is always so positive and he puts my mind at ease.

October 18, 2012

Dr. Rose is a wonderful Doctor. I have the utmost respect and confidence in him. He was prompt in treating me for a problem I am encountering. He is a caring doctor that relates to me on a personal level.

October 09, 2012

Dr. Rose and Julia Klein have both been very easy to talk to and are willing to answer questions about new medications and other symptoms or questions I may have.

August 20, 2012

Utah is so fortunate to have a facility staffed with such wonderful, caring professionals.

August 15, 2012

Dr. Rose has a excellent ability to help me feel comfortable and confident during the vist. That says a lot considering I hate seeing or doing any medical treatment.

August 02, 2012

Dr. Rose listens and then addresses my concerns specifically.

July 31, 2012

I brought up new concerns, I felt that they listened and understood the problem. They were able to tell me what the problem was and what may have caused it.

July 30, 2012

John Rose is the best. Every MS patient should want to see John Rose

July 06, 2012

Seeing Dr. Rose is always a good experience.

June 18, 2012

Dr. Rose is very patient and answers any questions I have. He shows concern for my well being.

June 07, 2012

I have been seeing Dr. Rose for some time. He is great.

May 12, 2012

Thank you, I feel like Dr. Rose really understands my symptoms.

May 09, 2012

I already have recommended Dr. Rose to others that seem to be having neurological problems. I just wish he could make a once a year trip to Idaho to see patients. We have to do an all day trip to be seen. Drive from Pocatello to SLC, be seen, eat, & drive all the way back. If he has several patients in Idaho, perhaps he could spend a day or two & get all the appointments taken care of. Just an idea :-)

May 09, 2012

Great job! I feel very blessed to have such great care providers as Julia Klein and Dr. Rose! I really can't imagine how they could be any better...unless they did house calls, that is!

May 02, 2012

All great. I would highly recommend to anyone.

April 09, 2012

Dr. Rose is a gem and I would recommend him to all of my friends.

April 04, 2012

Dr. Rose compitent and caring physician! I really appreciate my visit with him!

April 02, 2012

Dr. Rose is the best. I was hoping that he would have done more of my exam. The other neurologist was good but he was not Dr. Rose.

March 21, 2012

Dr Rose is the best!

March 07, 2012

Dr. Rose is absolutely the best neurologist one could ever wish for. He is so thorough, knows me well, is always so encouraging. His fellow, Giles, is also wonderful.

February 13, 2012

Dr. Rose is always so patient, kind, and caring.

February 06, 2012

Dr. Rose is amazing!

January 26, 2012

I saw my normal doctor and the new doctor who is completing clinical hours and these ratings apply to both.

January 19, 2012

I have the highest respect for Dr. Rose. For nearly 15 years, he has given me the highest quality of care. He and his staff are to be highly commended.

Academic Profile

Board Certification and Academic Information

Academic Departments Neurology - Professor
Academic Divisions Neuroimmunology
Board Certification American Board of Psychiatry & Neurology (Neurology)
National Board of Medical Examiners

Academic Office Locations

Academic Office Phone Number Academic Office Address
(801) 585-7575 Imaging & Neurosciences Center
729 Arapeen Dr
Salt Lake City, UT 84108

Academic Bio

Dr. John Rose received a B.A. in Biology from Johns Hopkins University and an MD from the University of Maryland. He then completed a residency in Neurology at the University Maryland, where he was Chief Resident in 1978-1979. He also completed a research fellowship at the NIH in Neuromuscular Disease and subsequently joined the NIH as a medical staff fellow in Neuroimmunology. Dr. Rose joined the staff at the University of Utah in 1985. He is currently a Professor in the Neurology Department at the University of Utah, Chief of Neurology at the Salt Lake City VA Hospital, and is an investigator the Neurovirology Research Laboratory at the Salt Lake VA Hospital.

Dr. Rose is the recipient of research grants to study neuroimmunology and multiple sclerosis (MS) and participates in clinical trials of new therapies for MS. His current VA grant is designed to improve imaging of the spinal cord in MS patients. Ongoing research includes biomarker, genetic and optic nerve imaging research in MS and Optic Neuritis. Dr. Rose is a member of the Data Coordinating and Analysis Center for the Network of Pediatric MS Centers supported by the National Multiple Sclerosis Society.

Recent Publications

Wynn D, Kaufman M, Montalban X, Vollmer T, Simon J, Elkins J, O’Niell G, Neyer L, Sheridan J, Wang C, Fong A and Rose J (corresponding author)CHOICE Investigators. Daclizumab in active relapsing forms of multiple sclerosis. Lancet Neurology 2010.

Carlson NG, Rojas MA, Redd JW, Tang P, Wood B, Hill KE, Rose JW. 2010. Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death. J Neuroinflammation 7:25

Rose JW, Carlson NG. 2011. Clinical Biomarkers in Multiple Sclerosis. Expert Opinion in Medical Diagnostics. In Press

Zollinger LV, Kim TH, Hill K, Jeong EK, Rose JW. Using diffusion tensor imaging and immunofluorescent assay to evaluate the pathology of multiple sclerosis. J Magn Reson Imaging. 2011 Mar;33(3):557-64.

Martins T, Rose J, Jaskowski T, Wilson A, Husebye D, Seraj H, and Hill H. Analysis of pro and anti-Inflammatory cytokine serum concentrations in multiple sclerosis patients utilizing a multiplexed Immunoassay. American Journal of Clinical Pathology in Press 2011.

Minalga E, Rose J, Choi SE, Jeong EK, Kholmovaski E, Vijayakumr S, Parker D and Hadley R. A 20-channel coil for improve magnetic resonance imaging of the optic nerve. Concepts in Magnetic Resonance Part B (Magnetic Resonance Engineering) in Press 2011.


Education History

Type School Degree
Fellowship National Institute of Health
Fellowship National Institute of Health
Chief Resident University of Maryland
Chief Resident
Residency University of Maryland
Internship Maryland General Hospital
Professional Medical University of Maryland
Undergraduate Johns Hopkins University


Selected Provider Publications

Journal Article

  1. Carlson NG, Bellamkonda S, Schmidt L, Redd J, Huecksteadt T, Weber LM, Davis E, Wood B, Maruyama T, Rose JW (2015). The role of the prostaglandin E2 receptors in vulnerability of oligodendrocyte precursor cells to death. Journal of Neuroinflammation, 12(1), 101.
  2. Charvet LE, Cleary RE, Vazquez K, Belman AL, Krupp LB (2014). Social cognition in pediatric-onset multiple sclerosis (MS). Mult Scler, 20(11), 1478-84.
  3. Charvet LE, ODonnell EH, Belman AL, Chitnis T, Ness JM, et al (2014). Longitudinal evaluation of cognitive functioning in pediatric ultiple sclerosis: report from the "US Pediatric Multiple Sclerosis Network". Mult Scler, 20(11), 1502-10.
  4. Casper TC, Rose JW, Roalstad S, Waubant E, Aaen G, Belman A, Chitnis T, Gorman M, Krupp L, Lotze TE, Ness J, Patterson M, Rodriguez M, Weinstock-Guttman B, Browning B, Graves J, Tillema JM, Benson L, Harris Y (2014). The US Network of Pediatric Multiple Sclerosis Centers: Development, Progress, and Next Steps. J Child Neurol, 09/30/2014, 1-7.
  5. Graves J, Grandhe S, Weinfurtner K, Krupp L, Belman A, Chitnis T, Ness J, Weinstock-Guttman B, Gorman M, Patterson M, Rodriguez M, Lotze T, Aaen G, Mowry EM, Rose JW, Simmons T, Casper TC, James J, Waubant E (2014). Protective environmental factors for neuromyelitis optica. Neurology, 83(21), 1923-9.
  6. Sheridan JP, Robinson RR, Rose JW (2014). Daclizumab, an IL-2 modulating antibody for treatment of multiple sclerosis. Expert Rev Clin Pharmacol, 7(1), 9-19.
  7. Yonnet GJ, Fjeldstad AS, Carlson NG, Rose JW (2013). Advances in the management of neurogenic detrusor overactivity in multiple sclerosis. International Journal of MS Care, 15(2), 66-72.
  8. Martins TB, Rose JW, Gardiner GL, Kusukawa N, Husebye D, Hill HR (2013). Cell-based reporter gene assay for therapy-induced neutralizing antibodies to interferon-beta in multiple sclerosis. J Interferon Res, 33(2), 52-7.
  9. Carlson NG, Rose JW (2013). Vitamin D as a clinical biomarker in multiple sclerosis. Expert Opin Med Diagn, 7(3), 231-42.
  10. Seo HS, Kim SE, Rose JW, Hadley JR, Parker DL, Jeong EK (2013). Diffusion tensor imaging of extraocular muscle using two-dimensional single-shot interleaved multiple inner volume imaging diffusion-weighted EPI at 3 tesla. J Magn Reson Imaging, 38(5), 1162-1168.
  11. Sato F, Martinex NE, Shahid M, Rose JW, Carlson NG, Tsunoda I (2013). Resveratrol exacerbates both autoimmune and viral models of multiple sclerosis. Am J Pathol, 183(5), 1390-6.
  12. Merrill RP, Hadley JR, Minalga E, Kholmovski EG, Vijayakumar S, Kim SE, Quigley EP, Parker DL, Rose JW (2012). A 28-channel coil array for improved imaging of the optic nerve. Sci Transl Med, 41B(3), 73-84.
  13. Langer HF, Choi EY, Zhou H, Schleicher R, Chung KJ, Tang Z, Gobel K, Bdeir K, Chatzigeorgiou A, Wong C, Bhatia S Kruhlak MJ, Rose JW, Burns JB, Hill KE, Qu H, Zhang Y, Lehrmann E, Becker KG, Wang Y, Simon DI, Nieswandt B, Lambris JD, Li X, Meuth SG, Kubes P, Chavakis T (2012). Platelets contribute to the pathogenesis of experimental autoimmune encephalomyelitis. Circ Res, 110(9), 1202-10.
  14. Fjeldstad AS, Carlson NG, Rose JW (2012). Optical coherence tomography as a biomarker in multiple sclerosis. Expert Opin Med Diagn, 6(6), 593-604.
  15. Minalga E, Rose JW, Choi SE, Jeong EK, Kholmovski E, et al (2011). A 20-channel coil for improved magnetic resonance imaging of the optic nerve. Concepts Magn Reson B Magn Reson Eng, 25(39B(1)), 26-36.
  16. Rose JW, Carlson NG (2011). Clinical biomarkers in multiple sclerosis. Expert Opin Med Diagn, 5(3), 213-26.
  17. Waldman AT, Gorman MP, Rensel MR, Austin Te, Hertz DP, et al (2011). Management of pediatric central nervous system demyelinating disorders: consensus of United States neurologists. J Child Neurol, 26(6), 675-82.
  18. Martins TB, Rose JW, Jaskowski TD, Wilson AR, Husebye D, Seraj HS, Hill HR (2011). Analysis of proinflammatory and anti-inflammatory cytokine serum concentrations in patients with multiple sclerosis by using a multiplexed immunoassay. Am J Clin Pathol, 136(5), 696-704.
  19. Zollinger LV, Kim TH, Hill K, Jeong EK, Rose JW (2011). Using diffusion tensor imaging and immunofluorescent assay to evaluate the pathology of multiple sclerosis. J Magn Reson Imaging, 33(3), 557-64.
  20. Fjeldstad AS, McDaniel J, Witman MA, Ives SJ, Zhao J, Rose JW, Hannon J, Wray DW, Richardson RS (2011). Vascular function and multiple sclerosis. J Neurol, 258(11), 2036-42.
  21. Carlson NG, Rojas MA, Redd JW, Tang P, Wood B, Hill KE, Rose JW (2010). Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death. J Neuroinflammation, 7, 25.
  22. Kim TH, Zollinger L, Shi XF, Kim SE, Rose J, Patel AA, Jeong EK (2010). Quantification of diffusivities of the human cervical spinal cord using a 2D single-shot interleaved multisection inner volume diffusion-weighted echo-planar imaging technique. AJNR Am J Neuroradiol, 31(4), 682-7.
  23. Wynn D, Kaufman M, Montalban X, Vollmer T, Simon J, Elkins J, ONeill G, Neyer L, Sheridan J, Wang C, Fong A, Rose JW (2010). Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta. Lancet Neurol, 9(4), 381-90.
  24. Ford C, Goodman AD, Johnson K, Kachuck N, Lindsey JW, Lisak R, Luzzio C, Myers L, Panitch H, Preiningerova J, Pruitt A, Rose J, Rus H, Wolinski J (2010). Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate. Mult Scler, Mar(3), 342-50.
  25. Mehta LR, Rose JW (2009). Recurrent granuloma annulare during treatment with daclizumab. Mult Scler, 15(4), 527-8.
  26. Rose JW (2009). Multiple sclerosis: evidence of maternal effects and an increasing incidence in women. Neurology, 73(8), 587-9.
  27. Rojas MA, Carlson NG, Miller TL, Rose JW (2009). Long-term daclizumab therapy in relapsing-remitting multiple sclerosis. Ther Adv Neurol Disord, 2(5), 291-7.
  28. Burt RK, Loh Y, Cohen B, Stefoski D, Balabanov R, Katsamakis G, Oyama Y, Russell EJ, Stern J, Muraro P, Rose JW, Testori A, Bucha J, Jovanovic B, Milanetti F, Storek J, Volterelli JC, Burns WH (2009). Autologous non-myeloablative heamtopoetic stem cell transplantation for relapsing and remitting multiple sclerosis. Lancet Neurol, 8, 244-53.
  29. Kim T, Zollinger L, Shu X, Rose JW, Jeong E (2009). Diffusion tensor imaging of ex vivo cervical spinal cord specimens: the immediate and long term effects of fixation on diffusivity. Anat Rec, 292, 234-41.
  30. Wolinski JS, Sochat T, Weiss S, Ladkani D PROMiSe Trial Study Group J Rose site PI (2009). Glatiramer acetate treatment in PPMS: why males appear to respond favorably. J Neurol Sci, 15, 286-928.
  31. Carlson NG, Rojas MA, Black JD, Redd JW, Hille J, Hill KE, Rose JW (2009). Microglial inhibition of neuroprotection by antagonists of the EP1 prostaglandin E2 receptor. J Neuroinflammation, 6, 5.
  32. Rose JW, Foley JF, Carlson NG (2009). Monoclonal antibody treatments for multiple sclerosis. Curr Treat Options Neurol, 11(3), 211-20.
  33. Hill KE, Clawson SA, Rose JW, Carlson NG, Greenlee JE (2009). Cerebellar Purkinje cells incorporate immunoglobulins and immunotoxins in vitro: implications for human neurological disease and immunotherapeutics. J Neuroinflammation, 6, 31.
  34. Brettschneider J, Jaskowski TD, Tumani H, Abdul S, Husebye D, Seraj H, Hill HR, Fire E, Spector L, Yarden J, Dotan N, Rose JW (2009). Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases. J Neuroimmunol, 217(1-2), 95-101.
  35. Wolinsky JS (2003). The diagnosis of primary progressive multiple sclerosis. J Neurol Sci, 206(2), 145-52.

Book Chapter

  1. Jacobson S, Rose J, Flerlage M, Mingioli E, McFarlin D, McFarland F (1986). Measles virus-specific human cytotoxic T cells generated in bulk cultures: Analysis of measles virus antigenic specificity. In Mahy BWJ (Ed.), The Biology of Negative Strand Viruses. Elsevier Biomedical Press.

Book Review

  1. Rose JW (1984). Neuroimmunology. [Review of the book ].


  1. Rose JW (August 2012). Anti-CD25 immunotherapy: regulating the regulators. Sci Transl Med, 4(145), 145fs25.
  2. Rose J (2009). Multiple Sclerosis: Evidence of Maternal Effects and an Increasing Incidence in Women. Neurology, 73(8), 578-9.
  3. Rose JW (2009). Multiple sclerosis: evidence of maternal effects and an increasing incidence in women. Neurology, 73(8), 578-9.


  1. Mehta LR, Rose JW (2009). Recurrent granuloma annulare during treatment with daclizumab [Letter to the editor]. Mult Scler, 15(4), 527-8.


  1. Tremlett H, Fadrosh D, Lynch S, Hart J, Gravas J, Lulu S, Aaen G, Belman A, Benson L, Casper C, Chitnis T, Gorman M, Krupp L, Lotze T, Ness J, Roalstac S, Rodriquez M, Rose JW, Tillema JM, Weinstock-Guttman B, Waubant E (2015). Gut Microbiome in Early Pediatric Multiple Sclerosis: A Case-control Study [Abstract]. Neurology, 84(14 Supplement), P4.027.
  2. Wiendl H, Havrdova E, Rose JW, Riester K, Tsao C, Greenberg S (2015). Daclizumab HYP Versus Interferon β-1a Across Patient Demographic and Disease Activity Subgroups in the DECIDE Phase 3 Study [Abstract]. Neurology, 84(14 Supplement), P4.007.
  3. Sand IK, Fabian M, Cook L, Chehade M, Masilamani M, Kraus T, Farrell C, Phelps S, Riffle ME, Rose JW, Moran T, Lublin F (2015). An Open Label Add-on Trial of Cetirizine for Neuromyelitis Optica [Abstract]. Neurology, 84(14 Supplement), P4.003.
  4. Wang V, Clardy T, Rose JW, Burns J, Carlson N, Greenlee J, Clardy S (2015). Neuromyelitis Optica in Veterans [Abstract]. Neurology, 84(14 Supplement), P1.104.
  5. Kappos L, Selmaj K, Arnold D, Havrdova E, Boyko A, Kaufman M, Wiendl H, Rose JW, Greenberg S, Sweetser M, Riester K, Elkins J (2015). Daclizumab HYP Versus Interferon Beta-1a in Relapsing-remitting Multiple Sclerosis: Primary Results of the DECIDE Study [Abstract]. Neurology, 84(14 Suppliment), S4.003.
  6. McDonald J, Graves J, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tilleman JM, Hart J, Ness J, Rubin J, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Mar S, Barcellos L, Rose JW, Roalstad S, Simmons T, Casper TC, Waubant E (2015). A Case-control Study of Dietary Salt Intake and Risk of Pediatric Multiple Sclerosis (MS). Washington D.C [Abstract]. Neurology, 84(14 Supplement), S38.003.
  7. Seminatore B, Graves J, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema JM, Hart J, Ness J, Rubin J, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Mar S, Barcellos L, Rose JW, Roalstad S, Simmons T, Casper C, Waubant E (2015). Fat, Fiber, and Pediatric MS [Abstract]. Neurology, 84(14 Supplement), S38.002.
  8. Rose JW, Wiendl H, Arnold D, Kappos L, Havrdova E, Selmaj K, Boyko A, Kaufman M, Greenberg S, Sweetser M, Riester K, Elkins J (2015). Daclizumab HYP Reduced Brain MRI Lesion Activity Compared with Interferon Beta-1a: Results from the DECIDE Study [Abstract]. Neurology, 84(14 Supplement), P7.252.
  9. Selmaj K, Kappos L, Arnold D, Havrdova E, Boyko A, Kaufman M, Wiendl H, Rose JW, Greenberg S, Riester K, Sweetser M, Elkins J (2015). Safety and Tolerability Results from the DECIDE Study: A Phase 3 Active-comparator Study of Daclizumab HYP in Relapsing-remitting Multiple Sclerosis [Abstract]. Neurology, 84(14 Supplement), P7.230.
  10. Paz Soldan M, Schmidt L, Wood B, Rose JW, Carlson N (2015). Prostaglandin F2a Receptor Mediates Oligodendrocyte Precursor Injury/Death: Potential Rose in Multiple Sclerosis. Washington D.C [Abstract]. Neurology, 84(14 Supplement), P5.210.
  11. Rose JW, Quigley E, Anderson J, Kim S, Jeong EK, Minalga E, Merrill R, Parker D, Hadley R (2009). Imaging of the optic nerve with improved radiofrequency toils for 3T MRI [Abstract]. First International Conference on Inflammation and Retinal Disease: Complement Biology and Pathology, Knossos, Crete.
  12. Tumani H, Brettschneider J, Jakowski T, Abdul S, Husebye D, Seraj H, Hill H, Fire E, Spector L, Dotan N, Rose JW (2009). Anti-GAGA4 IgM assay may distinguish primary progressive multiple sclerosis from relapsing remitting multiple sclerosis patients [Abstract]. ACTRIMS, Atlanta, Geogia.
  13. Carlson N, Rojas M, Redd J, Tang P, Wood B, Hill K, Rose JW (2009). Cyclooxygenase-2 expression in oligodendrocytes increases sensitiity to excitotoxic death [Abstract]. European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Dusseldorf, Germany.
  14. Merrill R, Hadley R, Minalga E, Parker D, Vijayakumar S, Choi SEK, Bell L, Rose JW (2009). An improved 28 channel array for optic nerve imaging [Abstract]. International Society for Magnetic Resonance Imaging.
  15. Kim T, Kim SE, Patel A, Zollinger L, Rose JW, Jeong EK (2009). Diffusion tensor imaging of human spinal cords in cervical myelopathy [Abstract]. International Society for Magnetic Resonance Imaging, Honolulu, Hawaii.
  16. Carlson N, Rojas M, Black J-D, Redd J, Hill K, Rose JW (2008). Neuroprotection by EP1 prostanoid receptor antagonists is modulated by microglia [Abstract]. Society for Neuroscience, Washington, DC.
  17. Carlson N, Rojas M, Redd J, Wood B, Hill K, Rose JW (2008). The role of COX-2 in experimental oligodendrocytes death and demyelination [Abstract]. International society for Neuroimmunology, Dallas, Texas.
  18. Tsunoda I, Rose JW, Carlson N (2008). Treatment on an animal model for MS with resveratrol, a red wine component [Abstract]. International Society for Neuroimmunology, Dallas, Texas.
  19. Burt R, Cohen B, Stefoski D, Balabanov R, Katsamakis G, Rose JW, Testori A, Muraro P, Storek J and Voltarelli J (2008). Autologous non myeloablative hematopoetic stem cell transplantation for relapsing multiple sclerosis [Abstract]. ECTRIMS, Montreal, Canada.
  20. Jaskowski T, Husebye D, Yarden J, Spector L, Fire E, Dotan N, Hill H, Rose JW (2008). Performance of an anti-GAGA4 IgM assay in distinguishing MS patients from control groups in a US cohort: a cross sectional retrospective study [Abstract]. ECTRIMS, Montreal, Canada.
  21. Carlson N, Rojas M, Redd J, Wood B, Hill K, Rose JW (2008). A COX-2 inhibitor limits demyelination in a murine model of MS and protects oligodendrocytes from excitotoxic death in culture [Abstract]. ECTRIMS, Montreal, Canada.
  22. Hadley R, Merrill R, Minalga E, Parker D, Rose JW (2008). Improved radio frequency coils for 3T magnetic resonance imaging of the optic nerve [Abstract]. ECTRIMS, Monteral, Canada.
  23. Tsunoda I, Carlson N, Rose JW (2008). Treatment with a red wine component, resveratrol, in a virus induced model for MS [Abstract]. ECTRIMS, Montreal, Canada.
  24. Mehta L, Rose JW (2008). Recurrent granuloma annulare occurring during treatment with daclizumab [Abstract]. ECTRIMS, Montreal, Canada.
  25. Rose JW, Jaskowski T, Husebye D, Seraj H, Hill H, Carlson N (2008). Anti-thyroid antibodies identify a subgroup of multiple sclerosis patients [Abstract]. ECTRIMS, Montreal, Canada.

Clinical Trials

Clinical Trials

Video & News